Overview of new combinaton therapies in acute myeloid leukemia (AML)
Naval G. Daver
Preliminary results of the AIM trial of ibrutinib and venetoclax in mantle cell lymphoma
Mechanism of action of venetoclax (ABT-199) and its side effects
Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian
Panel discussion on mantle cell lymphoma
Constantine Tam et al.